Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.
暂无分享,去创建一个
K. Jellinger | A. Becker | I. Blümcke | H. Lassmann | C. Bien | A. Vincent | M. Barnett | J. Schlegel | D. Reuss | J. Bauer | F. Graus | I. Sutton | T. Ribalta | A. Vincent
[1] R. Balice-Gordon,et al. Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome , 2011, Neurology.
[2] P. Convers,et al. Brain immunohistopathological study in a patient with anti‐NMDAR encephalitis , 2011, European journal of neurology.
[3] J. Dalmau,et al. GABAB receptor antibodies in limbic encephalitis and anti-GAD–associated neurologic disorders , 2011, Neurology.
[4] R. Balice-Gordon,et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis , 2011, The Lancet Neurology.
[5] J. Delrieu,et al. [Autoimmune channelopathies]. , 2011, La Revue de medecine interne.
[6] R. Balice-Gordon,et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series , 2010, The Lancet Neurology.
[7] A. Vincent,et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia , 2010, Brain : a journal of neurology.
[8] J. Dalmau,et al. Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study , 2010, Journal of Neurology.
[9] D. Kullmann,et al. N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes , 2010, Brain : a journal of neurology.
[10] Xiaoyu Peng,et al. Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis , 2010, The Journal of Neuroscience.
[11] H. Urbach,et al. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis , 2010, Annals of neurology.
[12] A. Vincent,et al. The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins , 2010, Current opinion in neurology.
[13] G. Martino,et al. Clinico-pathological findings in a patient with progressive cerebellar ataxia, autoimmune polyendocrine syndrome, hepatocellular carcinoma and anti-GAD autoantibodies , 2010, Journal of the Neurological Sciences.
[14] D. Friedman,et al. Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen , 2010, The Lancet Neurology.
[15] J. Dalmau,et al. Antibodies and neuronal autoimmune disorders of the CNS , 2010, Journal of Neurology.
[16] M. Rosenfeld,et al. Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma , 2009, Acta Neuropathologica.
[17] C. Good,et al. HISTOPATHOLOGY OF VGKC ANTIBODY–ASSOCIATED LIMBIC ENCEPHALITIS , 2009, Neurology.
[18] A. Becker,et al. CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery. , 2009, Brain : a journal of neurology.
[19] R. Kalb,et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location , 2009, Annals of neurology.
[20] C. Elger,et al. Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy. , 2009, Archives of neurology.
[21] E. Cho,et al. Immunoglobulins and complement in postmortem multiple sclerosis tissue , 2009, Annals of neurology.
[22] Xiaoyu Peng,et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies , 2008, The Lancet Neurology.
[23] M. Rosenfeld,et al. Paraneoplastic syndromes of the CNS , 2008, The Lancet Neurology.
[24] D. Murman,et al. An autopsy case of limbic encephalitis with voltage‐gated potassium channel antibodies , 2007, European journal of neurology.
[25] C. Elger,et al. Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy , 2007, Neurology.
[26] J. Dalmau,et al. Limbic Encephalitis and Variants: Classification, Diagnosis and Treatment , 2007, The neurologist.
[27] C. Elger,et al. Astrocytes are a specific immunological target in Rasmussen's encephalitis , 2007, Annals of neurology.
[28] N. Karandreas,et al. Bilateral drop foot due to thoracic disc herniation , 2007, European journal of neurology.
[29] J. Winer,et al. Autoimmune limbic encephalitis causing fits, rapidly progressive confusion and hyponatraemia. , 2006, Age and ageing.
[30] K. Digre,et al. Early pathologic findings and long-term improvement in anti-Ma2–associated encephalitis , 2006, Neurology.
[31] J. Honnorat,et al. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force , 2006, European journal of neurology.
[32] H. Urbach,et al. VGKC-Antikörper-assoziierte limbische Enzephalitis , 2005, Der Nervenarzt.
[33] H. Wieser,et al. Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis , 2004 .
[34] B. Boeve,et al. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody , 2004, Neurology.
[35] M. Rossor,et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. , 2004, Brain : a journal of neurology.
[36] R. Koup,et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. , 2003, Journal of immunological methods.
[37] J. Warren,et al. Pathological evidence of encephalomyelitis in the stiff man syndrome with anti-GAD antibodies , 2002, Journal of Clinical Neuroscience.
[38] D. Hafler,et al. Amendment history : Corrigendum ( June 2002 ) GAD 65-reactive T cells are activated in patients with autoimmune type 1 a diabetes , 2018 .
[39] C. Elger,et al. Destruction of neurons by cytotoxic T cells: A new pathogenic mechanism in rasmussen's encephalitis , 2002, Annals of neurology.
[40] A. Saiz,et al. Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis , 2002, Acta Neuropathologica.
[41] C. Solaro. High-dose intravenous immune globulin for stiff-person syndrome. , 2002, The New England journal of medicine.
[42] G. Escaramís,et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. , 2001, Brain : a journal of neurology.
[43] G. M. Halmágyi,et al. Paraneoplastic brain stem encephalitis in a woman with anti-Ma2 antibody , 2001, Journal of neurology, neurosurgery, and psychiatry.
[44] J. Palace,et al. Pathogenic autoantibodies to neuronal proteins in neurological disorders , 1999, Journal of Neuroimmunology.
[45] P. De Camilli,et al. Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma , 1999, Journal of neurology, neurosurgery, and psychiatry.
[46] P. van Endert,et al. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes , 1995, The Journal of experimental medicine.
[47] Antigen presentation and cytotoxic T lymphocyte killing studied in individual, living cells. , 1994, Virology.
[48] J. Dalmau,et al. Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti‐Hu‐associated paraneoplastic encephalomyelitis , 1994, Neurology.
[49] H. Ploegh,et al. HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. , 1990, International immunology.
[50] A. Engel,et al. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells , 1984, Annals of neurology.